newsfilter
← Latest News
GlobeNewswire·

Quantum BioPharma Ltd. (NASDAQ: QNTM) Developing Patented, First-in-Class MS Treatment That Offers Different Approach

NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands